Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-235.90%
↑ 92% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-3060.60%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -235.90% | +45.1% |
| 2024 | -429.90% | -40.6% |
| 2023 | -305.83% | +48.3% |
| 2022 | -591.93% | +91.9% |
| 2021 | -7292.42% | +53.3% |
| 2020 | -15628.84% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |